Endoscopy Devices are medical devices used to examine internal organs for diagnosis and treatment of diseases. A Capsule Endoscope consists of a video capsule, which takes images of the digestive tract every second for eight hours, which is used to diagnose intestinal tract diseases, as an alternate to more intrusive conventional endoscopy. GlobalData uses proprietary data and analytics to provide a comprehensive report on the capsule endoscopes devices market, including market shares of different players within France. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the capsule endoscopes market in France was Medtronic and Olympus.
A Capsule Endoscope is comprised of four Light Emitting Diodes (LEDs), a color camera chip, a lens, a radio frequency transmitter, two batteries, and an antenna. The capsule is enclosed in a biocompatible material to prevent it’s reaction with the digestive fluids. The Capsule Endoscope is a single-use device which moves into the gastrointestinal tract by peristalsis and is excreted naturally.
The value of the capsule endoscopes devices market within France was expected to be over $7m in 2023.
For the latest complete market share analysis of capsule endoscopes device market in France, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
